EFFICACY AND SAFETY RESULTS OF INVOKE-2: A PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED STUDY EVALUATING AL002 IN EARLY ALZHEIMER&#39;S DISEASE

AL002 - Alector, AbbVie

https://cslide.ctimeetingtech.com/adpd25/attendee/confcal/show/session/120

Catherine Mummery; A.J. Mayorga; Adam Simmons; Brady Burgess; Tuan Nguyen; Jingjing Gao; Li Shi; Caiyan Li Purcell; Michael Grundman; Giacomo Salvadore; GAry Romano

Mar 11, 2025